Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Andre

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 28, 2024
Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategiesS Ziane Bouziane, L Mans, A-M Bucalau, et al.
Annals of the New York Academy of Sciences|July 15, 2005
Diagnostic value of anti-F-actin antibodies in a French multicenter studyP Chretien-Leprince, E Ballot, C Andre, et al.
Pediatric Blood & Cancer|December 29, 2025
Tumor-Infiltrating Lymphocyte Adoptive Cell Therapy With PD-1 Blockade in Pediatric Chemotherapy-Resistant OsteosarcomaHelen Thut, Reto Ritschard, Katharina Glatz, et al.
Eclinicalmedicine|December 18, 2023
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trialMaya C Andre, Carlos Sanchez, Sabrina Bressieux-Degueldre, et al.
International Journal of Molecular Sciences|September 13, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and MelanomaSedigheh Givi, Benedikt J Lohnes, Saber Ebrahimi, et al.
The Pediatric Infectious Disease Journal|January 19, 2024
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in ChildrenGeraldine Blanchard-Rohner, Carlos Sanchez, Maya C Andre, et al.
The Lancet. Child & Adolescent Health|February 6, 2023
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trialTatjana Welzel, Andrew Atkinson, Nina Schöbi, et al.
The British Journal of Nutrition|December 10, 2020
Effects of dietary fibre intake in chemotherapy-induced mucositis in murine modelB Gallotti, I Galvao, G Leles, et al.
Frontiers in Pediatrics|August 20, 2021
X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children-A Case ReportSeraina Prader, Nicole Ritz, Frédéric Baleydier, et al.
Frontiers in Pediatrics|June 14, 2021
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in SwitzerlandLuregn J Schlapbach, Maya C Andre, Serge Grazioli, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|May 28, 2024
Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategiesS Ziane Bouziane, L Mans, A-M Bucalau, et al.
Annals of the New York Academy of Sciences|July 15, 2005
Diagnostic value of anti-F-actin antibodies in a French multicenter studyP Chretien-Leprince, E Ballot, C Andre, et al.
Pediatric Blood & Cancer|December 29, 2025
Tumor-Infiltrating Lymphocyte Adoptive Cell Therapy With PD-1 Blockade in Pediatric Chemotherapy-Resistant OsteosarcomaHelen Thut, Reto Ritschard, Katharina Glatz, et al.
Eclinicalmedicine|December 18, 2023
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trialMaya C Andre, Carlos Sanchez, Sabrina Bressieux-Degueldre, et al.
International Journal of Molecular Sciences|September 13, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and MelanomaSedigheh Givi, Benedikt J Lohnes, Saber Ebrahimi, et al.
The Pediatric Infectious Disease Journal|January 19, 2024
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in ChildrenGeraldine Blanchard-Rohner, Carlos Sanchez, Maya C Andre, et al.
The Lancet. Child & Adolescent Health|February 6, 2023
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trialTatjana Welzel, Andrew Atkinson, Nina Schöbi, et al.
The British Journal of Nutrition|December 10, 2020
Effects of dietary fibre intake in chemotherapy-induced mucositis in murine modelB Gallotti, I Galvao, G Leles, et al.
Frontiers in Pediatrics|August 20, 2021
X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children-A Case ReportSeraina Prader, Nicole Ritz, Frédéric Baleydier, et al.
Frontiers in Pediatrics|June 14, 2021
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in SwitzerlandLuregn J Schlapbach, Maya C Andre, Serge Grazioli, et al.
Pageof 16